Chemoinformaics analysis of 2,4-DIMETHYLUNDECANE
| Molecular Weight | 184.367 | nRot | 8 |
| Heavy Atom Molecular Weight | 156.143 | nRig | 0 |
| Exact Molecular Weight | 184.219 | nRing | 0 |
| Solubility: LogS | -6.568 | nHRing | 0 |
| Solubility: LogP | 6.351 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 40.3802 |
| nHD | 0 | BPOL | 28.0898 |
| QED | 0.464 |
| Synth | 2.312 |
| Natural Product Likeliness | 0.819 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.382 |
| MDCK | 0.0000102 |
| BBB | 0.485 |
| PPB | 0.977807 |
| VDSS | 2.941 |
| FU | 0.0229166 |
| CYP1A2-inh | 0.753 |
| CYP1A2-sub | 0.259 |
| CYP2c19-inh | 0.56 |
| CYP2c19-sub | 0.685 |
| CYP2c9-inh | 0.47 |
| CYP2c9-sub | 0.935 |
| CYP2d6-inh | 0.04 |
| CYP2d6-sub | 0.042 |
| CYP3a4-inh | 0.158 |
| CYP3a4-sub | 0.125 |
| CL | 7.537 |
| T12 | 0.119 |
| hERG | 0.041 |
| Ames | 0.004 |
| ROA | 0.031 |
| SkinSen | 0.838 |
| Carcinogencity | 0.042 |
| EI | 0.973 |
| Respiratory | 0.304 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.588317 |